Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UBIS (Asia) PCLBKK:UBIS-R +68.97%65 Days Sales Outstanding is 97.59 as of Jun. 2026, which is 12% below its 10-year median of 110.92. GuruFocus rates BKK:UBIS-R with a GF Score™ of 65/100 and a GF Value™ of ฿1.58. The stock has 7 warning signs investors should review. Among 1,583 Chemicals companies, UBIS (Asia) PCL ranks worse than 82.31% on this metric.
The historical rank and industry rank for UBIS (Asia) PCL's Days Sales Outstanding or its related term are showing as below:
BKK:UBIS-R'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 99.46 Med: 110.92 Max: 135.34
Current: 99.46
During the past 13 years, UBIS (Asia) PCL's highest Days Sales Outstanding was 135.34. The lowest was 99.46. And the median was 110.92.
BKK:UBIS-R's Days Sales Outstanding is ranked worse than 82.31% of 1583
companies
in the Chemicals industry
Industry Median: 63.91
vs BKK:UBIS-R: 99.46
UBIS (Asia) PCL's Days Sales Outstanding
declined
from Jun. 2025 (120.08) to Jun. 2026 (97.59).
UBIS (Asia) PCL (BKK:UBIS-R) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
UBIS (Asia) PCL Days Sales Outstanding Related Terms
UBIS (Asia) PCL Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for UBIS (Asia) PCL's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:UBIS-R vs LIN, SHW, ECL: Days Sales Outstanding Comparison
For the Specialty Chemicals subindustry, UBIS (Asia) PCL's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UBIS (Asia) PCL Days Sales Outstanding vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, UBIS (Asia) PCL's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where UBIS (Asia) PCL's Days Sales Outstanding falls into.
UBIS (Asia) PCL Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UBIS (Asia) PCL (BKK:UBIS-R) has a Days Sales Outstanding of 97.59 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on UBIS (Asia) PCL and its competitors. This is 12% below median its historical median of 110.92. Over the past decade, UBIS (Asia) PCL's Days Sales Outstanding has ranged from 99.46 to 135.34. According to the industry distribution chart, UBIS (Asia) PCL ranks #1303 out of 1583 companies in the Chemicals industry, placing it in the top 82.3%.
Is UBIS (Asia) PCL's Days Sales Outstanding too high?
UBIS (Asia) PCL's current Days Sales Outstanding of 97.59 is 12% below median its 10-year median of 110.92. Over the past 10 years, this metric has ranged from a low of 99.46 to a high of 135.34. The Chemicals industry median Days Sales Outstanding is 63.91. UBIS (Asia) PCL's value of 97.59 is 52.7% above this industry median. Based on the distribution chart, UBIS (Asia) PCL ranks #1303 out of 1583 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, UBIS (Asia) PCL has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does UBIS (Asia) PCL's Days Sales Outstanding compare to LIN and SHW?
According to the Chemicals industry distribution chart, UBIS (Asia) PCL ranks #1303 out of 1583 companies for Days Sales Outstanding. This places UBIS (Asia) PCL in the lower half of its industry. The industry median Days Sales Outstanding is 63.91. UBIS (Asia) PCL's value of 97.59 is 52.7% above this benchmark. Historically, UBIS (Asia) PCL's own Days Sales Outstanding has ranged from 99.46 to 135.34 over the past decade. While the company's 10-year median is 110.92 vs. the industry median of 63.91, UBIS (Asia) PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Chemicals company?
The median Days Sales Outstanding among Chemicals companies is 63.91, based on 1,583 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UBIS (Asia) PCL's current Days Sales Outstanding of 97.59 is 52.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on UBIS (Asia) PCL and its competitors. For the Chemicals industry, the median Days Sales Outstanding is 63.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UBIS (Asia) PCL's current Days Sales Outstanding is 97.59, which is 12% below median its own 10-year median of 110.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UBIS (Asia) PCL stock overvalued right now?
UBIS (Asia) PCL (BKK:UBIS-R) has a current Days Sales Outstanding of 97.59. The stock's GF Value™ is ฿1.58, compared to a current price of ฿1.69 — trading 6.9% above its estimated fair value. The current Days Sales Outstanding is 97.59, which is 12% below median its 10-year median of 110.92 and 52.7% above the Chemicals industry median of 63.91. UBIS (Asia) PCL's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For UBIS (Asia) PCL (BKK:UBIS-R), the current Days Sales Outstanding is 97.59 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UBIS (Asia) PCL (BKK:UBIS-R) Overvalued in 2026?
Based on GuruFocus' analysis, UBIS (Asia) PCL stock appears to be overvalued.
The current stock price of ฿1.69 is trading 6.9% above its estimated GF Value™ of ฿1.58.
Key valuation signals for BKK:UBIS-R:
Days Sales Outstanding: 97.59 (12% below median its 10-year median of 110.92)
GF Value™: ฿1.58 vs. price of ฿1.69 (6.9% above fair value)
Industry Position: 52.7% above the Chemicals median (#1303 of 1583)
No single metric tells the full story. See the BKK:UBIS-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UBIS (Asia) PCL is engaged in the business of manufacturing and distributing of sealing compounds, lacquers, and coatings used in can production and bottle closure for the food, beverage, and general industries. It operates in two business segments, each offering different products and services: Manufacturer and distributor of sealing compounds, lacquers and coatings and Other business The majority of the revenue is generated from the Manufacturer of sealing compounds, lacquers and coatings segment. Company operates in Thailand, China, and Others, with the majority of revenue from Other segment.
65GF Score
Get the complete analysis for BKK:UBIS-R
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:UBIS-R has been successfully added to your 
